… nonexposure to CNS drugs with prominent D2 receptor antagonist activity or 5-HT2A
receptor antagonist activity). Post hoc analyses were initially performed in patients in the HBBM …

… D2 receptor antagonist on the exploratory behaviors of mice in the hole-board test … reuptake
inhibitors and dopamine D2 receptor antagonist on the exploratory behaviors of mice in the …

… We hypothesize that mineralocorticoid receptor antagonists (MRA) on top of conventional
RAAS blockade change the angiotensin pattern resulting in cardio- and renoprotective effects. …

… , receptor subtype (5, 10, 30). In our second set of experiments, the CCK, receptor antagonist
… Contrary, the CCK, receptor antagonist L 365260 at the dose level of 10 mg/kg reversed …

… administration of low doses of NMDA receptor antagonists, this being particularly evident for
… , therapeutically relevant doses of NMDA receptor antagonists do not block, and may even …

… In conclusion, in the exploratory study, we demonstrated that a higher cumulative use of
H2RBs was associated with a reduced risk for non-small cell lung cancer in diabetic patients. …

… Secondary objectives were to test whether rhIL-1ra has biological activity, and to perform
an exploratory analysis of efficacy. The trial was conducted at an acute teaching hospital trust …

… anxiety (the open field exploratory behavior of non-habituated … (icv) significantly increased
exploratory activity in the central … -like action of NMDA receptor antagonists in mice and rats. …

… effect of the CCK receptor antagonists on the exploratory behaviour of experimentally naive
… , the BDZ receptor inverse agonists FG 7142 and DMCM, and the BDZ receptor antagonist …

… The results obtained in the present study support endothelin A receptor antagonism as
an approach for treating patients with CRPC. To confirm the survival signal observed in the …